Metraipolis › archive › dc_f395dcfa98ff
Teclistamab Monotherapy in Relapsed or Refractory Multiple Myeloma: A Real-World Focused Systematic Review and Meta-Analysis of Efficacy and Safety — Europe PMC PMID:42645793
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42645793
- DOI
- 10.3390/hematolrep18040054
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T05:19:17.756Z
- SHA-256 of the archived text
0095c7a448d8708159339b6660355c9941fe5b81cd37c716a58d3d93c3469836- Stable URL of this page
https://metraipolis.com/documento/dc_f395dcfa98ff
How to cite
Teclistamab Monotherapy in Relapsed or Refractory Multiple Myeloma: A Real-World Focused Systematic Review and Meta-Analysis of Efficacy and Safety — Europe PMC PMID:42645793 — Europe PMC (en), https://europepmc.org/article/MED/42645793 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f395dcfa98ff (Metraipolis archive dc_f395dcfa98ff, sha256 0095c7a448d8708159339b6660355c9941fe5b81cd37c716a58d3d93c3469836)
BibTeX
@misc{dcf395dcfa98ff,
title = {Teclistamab Monotherapy in Relapsed or Refractory Multiple Myeloma: A Real-World Focused Systematic Review and Meta-Analysis of Efficacy and Safety — Europe PMC PMID:42645793},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42645793},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f395dcfa98ff; sha256 0095c7a448d8708159339b6660355c9941fe5b81cd37c716a58d3d93c3469836},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42645793. Agents can read the archived copy with the MCP tool read_document.